Scandicain - Mepivacaine

SYNS CARBOCAINE MEPIVACAINE dl-MEPI-VACAINE N-METHYLHEXAHYDRO-2-PICOLINIC ACID, 2,6-DIAIETHYLANILlDE N-METHYL-2-PIPECOUC ACID, 2,6-DIMETHYL.ANILIDE N-METHYL-2-PIPECOLIC ACID, 2,6-XYLIDIDE ( )-l-METHYL-2, 6 -PIPECOLOXYIJDIDE SCANDICAIN SCANDICANE... 

Prior to LITT treatment all patients undergo CT and a contrast-enhanced MRI study at least 2 days prior to the intervention. After localization of the tumor with CT, local anesthesia is achieved with 20-30 ml of 1% mepivacaine (Scandicain, AstraZeneca, Wedel, Germany). Distance to the lesion and the puncture angle are calculated electronically. 

First, 10 ml of 0.5% mepivacaine (Scandicain) is injected for local anesthesia. The one-step system applicator is advanced under CT fluoroscopy (Care vision, Siemens, Erlangen) directly in the planned route. CT fluoroscopy facilitates near real-time control of the applicator position and its relationship to the vital structures. After verified intratumoral positioning of the system, the inner mandrin is removed and a thermostable catheter is introduced. The flexible laser fiber (Medilas Dornier, Sunnydale, Calif., USA) is then inserted within (Vogl et al. 2004a). 

Informed consent is obtained from all patient. Prior to LITT treatment all patients undergo CT and a contrast-enhanced MRI study at least 2 days prior to the intervention. After localization of the tumor with CT local anesthesia was achieved with 20-30 ml of 1% mepivacaine (Scandicain, AstraZeneca, Wedel, Germany). Distance to the lesion and the puncture angle are calculated electronically. For targeting of both recurrent nasopharyngeal tumors and pleomorphic adenomas a subzygomatic approach to the lesion was chosen, which provided the best and safest access to the lesion. Lesions of the larynx and the floor of the mouth were punctured directly. After the procedure the needle track was closed with flbrin glue (Tissucol Duo S, Baxter, Vienna, Austria). 

---